Back

IASLC-ACLC 2022 - IASLC Asia Conference on Lung Cancer 2022

Oct 27 - Oct 29, 2022 | NaraJapan

LARVOL is not affiliated with IASLC Asia Conference on Lung Cancer 2022 and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 3 abstracts linked to Trials

Efficacy and Intracranial Activity of Tepotinib in Japanese Patients with MET Exon 14 Skipping NSCLC (VISION)

  • Poster

A Phase Ib Study of AK112, a PD-1/VEGF Bispecific Antibody, in Combination with Etoposide and Carboplatin in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

  • Oral

CRESTONE: Initial Efficacy and Safety of Seribantumab in Solid Tumors Harboring NRG1 Fusions

  • Oral